Your browser doesn't support javascript.
loading
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy.
Du, Xuexiang; Tang, Fei; Liu, Mingyue; Su, Juanjuan; Zhang, Yan; Wu, Wei; Devenport, Martin; Lazarski, Christopher A; Zhang, Peng; Wang, Xu; Ye, Peiying; Wang, Changyu; Hwang, Eugene; Zhu, Tinghui; Xu, Ting; Zheng, Pan; Liu, Yang.
Afiliação
  • Du X; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Health System, Washington, DC, 20010, USA.
  • Tang F; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Health System, Washington, DC, 20010, USA.
  • Liu M; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Health System, Washington, DC, 20010, USA.
  • Su J; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Health System, Washington, DC, 20010, USA.
  • Zhang Y; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Health System, Washington, DC, 20010, USA.
  • Wu W; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Health System, Washington, DC, 20010, USA.
  • Devenport M; OncoImmune, Inc., Rockville, MD, 20852, USA.
  • Lazarski CA; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Health System, Washington, DC, 20010, USA.
  • Zhang P; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Health System, Washington, DC, 20010, USA.
  • Wang X; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Health System, Washington, DC, 20010, USA.
  • Ye P; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Health System, Washington, DC, 20010, USA.
  • Wang C; Immutics, Inc., Sunnyvale, CA, 94085, USA.
  • Hwang E; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Health System, Washington, DC, 20010, USA.
  • Zhu T; Alphamab, Inc., Suzhou, Jiangsu, 215125, China.
  • Xu T; Alphamab, Inc., Suzhou, Jiangsu, 215125, China.
  • Zheng P; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Health System, Washington, DC, 20010, USA. pzheng@oncoimmune.com.
  • Liu Y; OncoImmune, Inc., Rockville, MD, 20852, USA. pzheng@oncoimmune.com.
Cell Res ; 28(4): 416-432, 2018 Apr.
Article em En | MEDLINE | ID: mdl-29472691
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Bloqueadores / Antígeno CTLA-4 / Ipilimumab / Antineoplásicos Imunológicos / Neoplasias Limite: Animals / Female / Humans / Male Idioma: En Revista: Cell Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Bloqueadores / Antígeno CTLA-4 / Ipilimumab / Antineoplásicos Imunológicos / Neoplasias Limite: Animals / Female / Humans / Male Idioma: En Revista: Cell Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos